Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021

The global pain management devices market is valued at an estimated USD 3.08 Billion in 2016 and is projected to grow at a CAGR of 8.5% during the forecast period of 2016 to 2021. A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restraining the growth of the global market.

The Asia-Pacific region has become an attractive destination for companies engaged in the manufacture of pain management device. The high growth opportunities in this regional segment can be attributed to a number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device. According to the U.S. Department of Commerce, Japan has one of the largest geriatric populations in the world, with at least 20% of its population aged 65 years and above. In 2012, 30 million people in Japan were aged above 65 years and this figure is projected to reach 39 million by 2030 and nearly 43 million by 2050. Driven by its high growth potential, leading companies operating in the market are focusing on expanding their presence in emerging APAC countries. In September 2013, DJO Global announced plans to launch 10 pain management device in India in a phased manner over the next five years. The company also planned to start its operations in India, starting with 40 distribution locations across the country.

As of 2015, Medtronic plc (Ireland) held the leadership position in the global pain management devices market. Over the last three years, the company adopted new product launches, alliances, geographic expansion, and inorganic growth strategies such as acquisitions and agreements to maintain its leading position in the market. St. Jude Medical, Inc. (U.S.) and Boston Scientific Corporation (U.S.) are the other key players in this market.

Stakeholders

• Pain Management Device Manufacturing Companies
• Distributors and Suppliers
• Government Bodies
• Research Institutions and Universities
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the pain management devices market into the following segments and subsegments:

Global Pain Management Devices Market, by Type

• Neuromodulation Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Spinal Cord Stimulation (SCS) Devices
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Cryoablation Devices
• Analgesic Infusion Pumps
  • Intrathecal Infusion Pumps
  • External Infusion Pumps

Global Pain Management Devices Market, by Application

• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Others (Pregnancy/Labor and Menstrual Pain, Sports Injuries, Post-operative Pain, and Trauma Pain)  

Global Pain Management Devices Market, by Mode of Purchase

• Over-the-counter Devices
• Prescription-based Devices

Global Pain Management Devices Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
• Asia-Pacific
  • India
  • China
  • Japan
• Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis:

• Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis:

• Further breakdown of the Rest of Asia-Pacific Pain management devices market into South Korea, Australia, New Zealand, and others
• Further breakdown of the Rest of the World Pain management devices market into Latin America, Middle East, and Africa

Company Information:

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
                    2.2.1.2 Primary Research
                    2.2.1.3 Key Data From Primary Sources
    2.3 Market Size Estimation Methodology
           2.3.1 Research Methodology: Bottom-Up Approach
           2.3.2 Research Methodology: Top-Down Approach
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study
    2.7 Limitations

3 Executive Summary (Page No. - 28)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 33)
    4.1 Global Pain Management Devices Market Overview (2016–2021)
    4.2 Geographical Snapshot of the Global Market
    4.3 Global Market, By Application and Region (2016)
    4.4 Global Market, By Mode of Purchase and Region (2016 vs 2021)

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Growing Demand for Long-Term Pain Management Among the Geriatric Population
                    5.3.1.2 Large Patient Population Base
                    5.3.1.3 Adverse Effects of Pain Medications
                    5.3.1.4 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
                    5.3.1.5 Established Reimbursement Scenario for Spinal Cord Stimulation (SCS) Devices in Developed Countries
                    5.3.1.6 Development of Novel Pain Management Devices
           5.3.2 Restraints
                    5.3.2.1 Low Awareness About the Availability and Use of Pain Management Devices
                    5.3.2.2 Shortage of Pain Specialists and Low Number of Pain Clinics in Several Countries
                    5.3.2.3 Existence of A Gap in Prevalence and Treatment of Pain
                    5.3.2.4 High Procedural and Purchase Cost of Pain Management Devices
           5.3.3 Opportunities
                    5.3.3.1 Increasing Number of Patients Suffering From Neuropathic Pain
                    5.3.3.2 Expanding Base of Pain Management Clinics/Centers Across the Globe
                    5.3.3.3 Strong Product Pipeline for Pain Management Devices
                    5.3.3.4 Stringent Regulations to Limit Opioid Pain Killer Prescriptions
           5.3.4 Challenges
                    5.3.4.1 Presence of Alternative Therapies for Pain Management
                    5.3.4.2 Use of Pain Medications as the First Line of Treatment for Pain Management
                    5.3.4.3 Stringent Regulatory Guidelines Delay the Adoption of Novel Devices

6 Industry Insights (Page No. - 57)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Wearable Devices
           6.2.2 Consolidation in the Pain Management Devices Market
           6.2.3 Rising Popularity of Rechargeable Spinal Cord Stimulators
    6.3 Porter’s Five Forces Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry

7 Global Pain Management Devices Market, By Type (Page No. - 62)
    7.1 Introduction
    7.2 Neurostimulation Devices
           7.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
                    7.2.1.1 Introduction of Advanced & Wearable TENS Devices
           7.2.2 Spinal Cord Stimulation (SCS) Devices
                    7.2.2.1 Cost Benefits of SCS Over Other Therapies
    7.3 Analgesic Infusion Pumps
           7.3.1 High Use of Infusion Pumps in Post-Operative Pain Management
           7.3.2 Intrathecal Infusion Pumps
           7.3.3 External Infusion Pumps
    7.4 Ablation Devices
           7.4.1 RF Ablation Devices
           7.4.2 Cryoablation Devices

8 Global Pain Management Devices Market, By Application (Page No. - 76)
    8.1 Introduction
    8.2 Neuropathic Pain
           8.2.1 High Prevalence of Diseases Associated With Neuropathic Pain
    8.3 Cancer Pain
    8.4 Facial Pain & Migraine
    8.5 Musculoskeletal Pain
    8.6 Other Applications

9 Global Pain Management Devices Market, By Mode of Purchase (Page No. - 87)
    9.1 Introduction
    9.2 Over-The-Counter Pain Management Devices
           9.2.1 Otc Pain Management Devices Unfold New Growth Avenues
    9.3 Prescription-Based Pain Management Devices

10 Pain Management Devices Market, By Region (Page No. - 92)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Rising Geriatric Population in the U.S.
                        10.2.1.2 Rising Patient Population Base
                        10.2.1.3 High Demand of Pain Management Devices for the Treatment of Post-Operative Pain
                        10.2.1.4 Large Number of Ongoing Clinical Trials
                        10.2.1.5 Favorable Reimbursement Scenario for SCS
                        10.2.1.6 Stringent Regulatory Policies
                        10.2.1.7 Lack of Reimbursement for TENS in the U.S.
             10.2.2 Canada
                        10.2.2.1 Reduced Healthcare Spending
                        10.2.2.2 Rising Prevalence of Chronic Disorders
     10.3 Europe
             10.3.1 Rising Aging Population in Europe
             10.3.2 Huge Patient Population Base
             10.3.3 Conferences to Increase Awareness of Pain Management Devices in the European Market
             10.3.4 New Product Launches and Product Approvals
             10.3.5 Organization of Campaigns to Raise Awareness About Pain Management Approaches
             10.3.6 Slow Economic Growth in Europe
             10.3.7 Changing Regulatory Policies
             10.3.8 Limited Awareness of New Pain Management Approaches
             10.3.9 Germany
                        10.3.9.1 Large Number of Ongoing Clinical Trials
                        10.3.9.2 Rising Aging Population and Cancer Incidence
                        10.3.9.3 Favorable Healthcare Reimbursement Scenario
             10.3.10 France
                        10.3.10.1 Rising Adoption of Pain Management Devices Due to Increased Patient Population
                        10.3.10.2 Availability of Proper Healthcare Facilities, Training, and Reimbursement for Pain Management Therapies
             10.3.11 U.K.
                        10.3.11.1 Large Patient Population Base
                        10.3.11.2 Rising Healthcare Expenditure
                        10.3.11.3 Presence of Noteworthy Number of Organizations Related to Pain Management
                        10.3.11.4 Availability of Funding for Research in Pain Management
                        10.3.11.5 Government Recommendations Encouraging Use of SCS
                        10.3.11.6 Safety Issues Related to Infusion Pumps
                        10.3.11.7 Low Penetration of Pain Management Devices in the Country
             10.3.12 RoE
                        10.3.12.1 Growing Patient Population
                        10.3.12.2 Rapidly Increasing Aging Population in the Region
                        10.3.12.3 Growing Preference Towards Home Use Pain Management Devices
                        10.3.12.4 Key Factors Hampering Market Growth
     10.4 Asia-Pacific
             10.4.1 Large Patient Population With Cancer, Diabetes, and Chronic Pain
             10.4.2 Improving Healthcare Infrastructure in Asian Countries
             10.4.3 Japan
                        10.4.3.1 Growing Patient Base
                        10.4.3.2 Increase in the Baby Boomer Population
                        10.4.3.3 Well-Developed Healthcare System
                        10.4.3.4 Inflow of Advanced Pain Management Devices
                        10.4.3.5 Rising Government Focus Towards the Development of the Medical Devices Industry
                        10.4.3.6 Pricing and Reimbursement Challenges for Foreign Suppliers
             10.4.4 China
                        10.4.4.1 Growing Diabetic Population
                        10.4.4.2 Increasing Disposable Income and Healthcare Spending
                        10.4.4.3 Extensive Use of Traditional Chinese Medicine (TCM) for Alleviating Pain
                        10.4.4.4 Uncertain and Changing Regulatory Environment
             10.4.5 India
                        10.4.5.1 Huge Addressable Market
                        10.4.5.2 Growing Number of Pain Management Centers
                        10.4.5.3 Rising Focus of Global Players
                        10.4.5.4 Growing Demand for Pain Management Devices
                        10.4.5.5 Conferences and Meetings on Neuromodulation & Pain Management in India
                        10.4.5.6 Rising Government Support
                        10.4.5.7 High Dependence of Patients on Low-Cost Generic Medicine
                        10.4.5.8 Key Factors Limiting the Growth of the Indian Market
             10.4.6 Rest of Asia-Pacific
                        10.4.6.1 South Korea Presents Significant Opportunities for Pain Management Devices in Asia
                        10.4.6.2 Large Number of Conferences in Australia
                        10.4.6.3 Ongoing Product Innovations in Singapore & Australia
     10.5 Rest of the World
             10.5.1 Increasing Incidences of Cancer in Latin America
             10.5.2 Aging Population
             10.5.3 Strict Regulations on Medical Devices in Brazil

11 Competitive Landscape (Page No. - 152)
     11.1 Overview
     11.2 Market Share Analysis
             11.2.1 Key Players in the Market
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches and Product Approvals
             11.3.2 Agreements, Alliances, and Contracts
             11.3.3 Geographical Expansions
             11.3.4 Mergers & Acquisitions
             11.3.5 Other Developments

12 Company Profiles (Page No. - 160)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     12.1 Introduction
     12.2 Medtronic PLC
     12.3 ST. Jude Medical, Inc.
     12.4 Boston Scientific Corporation
     12.5 Hospira, Inc. (A Subsidiary of Pfizer Inc.)
     12.6 Halyard Health, Inc.
     12.7 Smiths Medical
     12.8 B. Braun Melsungen AG
     12.9 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
     12.10 Becton, Dickinson and Company
     12.11 Nevro Corp.

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 190)
     13.1 Discussion Guide
     13.2 Introducing Rt: Real-Time Market Intelligence
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Available Customizations
     13.5 Related Reports

List of Tables (117 Tables)

Table 1 Access to Interdisciplinary Pain Management Services in Different Countries, 2012
Table 2 Global Pain Management Devices Market Size, By Type, 2014–2021 (USD Million)
Table 3 Pain Management Devices Market Size, By Region, 2014-2021(USD Million)
Table 4 Neurostimulation Devices Market Size, By Type, 2014-2021(USD Million)
Table 5 Neuromodulation Devices Market Size, By Region, 2014-2021(USD Million)
Table 6 Transcutaneous Electrical Nerve Stimulation Devices Market Size, By Region, 2014-2021(USD Million)
Table 7 Spinal Cord Stimulation Devices Market Size, By Region, 2014-2021(USD Million)
Table 8 Analgesic Infusion Pumps Market Size, By Type, 2014-2021(USD Million)
Table 9 Analgesic Infusion Pumps Market Size, By Region, 2014-2021(USD Million)
Table 10 Intrathecal Infusion Pumps Devices Market Size, By Region, 2014-2021(USD Million)
Table 11 External Infusion Pumps Devices Market Size, By Region, 2014-2021(USD Million)
Table 12 Ablation Devices Market Size, By Type, 2014-2021(USD Million)
Table 13 Ablation Devices Market Size, By Region, 2014-2021(USD Million)
Table 14 RF Ablation Devices Market Size, By Region, 2014-2021(USD Million)
Table 15 Cryoablation Devices Market Size, By Region, 2014-2021(USD Million)
Table 16 Global Market Size, By Application, 2014–2021 (USD Million)
Table 17 Neuropathic Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 18 Cancer Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 19 Facial Pain & Migraine Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 20 Musculoskeletal Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 21 Other Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 22 Global Pain Management Devices Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 23 Over-The-Counter Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 24 Prescription-Based Market Size, By Region, 2014–2021 (USD Million)
Table 25 Global Pain Management Devices Market Size, By Region, 2014–2021 (USD Million)
Table 26 North America: Pain Management Devices Market Size, By Country, 2014–2021 (USD Million)
Table 27 North America: Pain Management Devices Market Size, By Type, 2014–2021 (USD Million)
Table 28 North America: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 29 North America: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 30 North America: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 31 North America: Pain Management Devices Market Size, By Application, 2014–2021 (USD Million)
Table 32 North America: Pain Management Devices Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 33 U.S.: Pain Management Devices Market Size, By Type, 2014–2021 (USD Million)
Table 34 U.S.: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 35 U.S.: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 36 U.S.: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 37 U.S.: Pain Management Devices Market Size, By Application, 2014–2021 (USD Million)
Table 38 U.S.: Pain Management Devices Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 39 Canada: Market Size, By Type, 2014–2021 (USD Million)
Table 40 Canada: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 41 Canada: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 42 Canada: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 43 Canada: Pain Management Devices Market Size, By Application, 2014–2021 (USD Million)
Table 44 Canada: Pain Management Devices Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 45 Europe: Pain Management Devices Market Size, By Country, 2014–2021 (USD Million)
Table 46 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 47 Europe: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 48 Europe: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 49 Europe: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 52 Germany: Market Size, By Type, 2014–2021 (USD Million)
Table 53 Germany: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 54 Germany: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 55 Germany: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 56 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 57 Germany: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 58 France : Market Size, By Type, 2014–2021 (USD Million)
Table 59 France : Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 60 France : Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 61 France : Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 62 France : Market Size, By Application, 2014–2021 (USD Million)
Table 63 France : Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 64 U.K.: Market Size, By Type, 2014–2021 (USD Million)
Table 65 U.K.: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 66 U.K.: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 67 U.K.: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 68 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 69 U.K.: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 70 RoE: Market Size, By Type, 2014–2021 (USD Million)
Table 71 RoE: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 72 RoE: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 73 RoE: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 74 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 75 RoE: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 76 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Million)
Table 77 Asia-Pacific: Market Size, By Type, 2014–2021 (USD Million)
Table 78 Asia-Pacific: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 83 Japan: Market Size, By Type, 2014–2021 (USD Million)
Table 84 Japan: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 85 Japan: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 86 Japan: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 87 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 88 Japan: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 89 China: Market Size, By Type, 2014–2021 (USD Million)
Table 90 China: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 91 China: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 92 China: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 93 China: Market Size, By Application, 2014–2021 (USD Million)
Table 94 China: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 95 India: Market Size, By Type, 2014–2021 (USD Million)
Table 96 India: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 97 India: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 98 India: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 99 India: Market Size, By Application, 2014–2021 (USD Million)
Table 100 India: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 101 Rest of Asia-Pacific: Market Size, By Type, 2014–2021 (USD Million)
Table 102 Rest of Asia-Pacific: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 103 Rest of Asia-Pacific: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 104 Rest of Asia-Pacific: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 105 Rest of Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 106 Rest of Asia-Pacific: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 107 Rest of World: Market Size, By Type, 2014–2021 (USD Million)
Table 108 Rest of World: Neurostimulation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 109 Rest of World: Analgesic Infusion Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 110 Rest of World: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 111 Rest of World: Market Size, By Application, 2014–2021 (USD Million)
Table 112 Rest of World: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 113 New Product Launches and Product Approvals, 2012–2016
Table 114 Agreements, Alliances, and Contracts , 2012–2016
Table 115 Geographical Expansions, 2012–2016
Table 116 Mergers & Acquisitions, 2012-2016
Table 117 Other Developments, 2012-2016

List of Figures (43 Figures)

Figure 1 Global Pain Management Devices Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Market Share, By Key Player, 2015
Figure 5 Market Size, By Type (2016 vs 2021)
Figure 6 Market Share, By Application (2016 vs 2021)
Figure 7 Market Share, By Mode of Purchase (2016 vs 2021)
Figure 8 Geographical Snapshot of the Market, 2016
Figure 9 Growing Demand for Long-Term Pain Management Among the Geriatric Population—Primary Market Driver
Figure 10 APAC is the Most Lucrative Region for Market Players
Figure 11 U.S. to Command the Largest Share of the Market in 2016
Figure 12 Prescription-Based Segment to Dominate the Market in 2021
Figure 13 Market Segmentation
Figure 14 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Prevalence of Chronic Pain, By Age, 2011
Figure 16 Impact of Chronic Pain in the U.S.: Chronic Pain Affects More People Than Diabetes, Heart Disease, and Cancer Combined
Figure 17 Strong Competitive Landscaping of Pain Management Devices Over Other Products
Figure 18 Expanding Patient Population Base Driving Market Growth
Figure 19 Awareness of Spinal Cord Stimulation for Pain Management in Europe, 2013
Figure 20 Low Awareness Regarding the Availability and Use of Pain Management Devices is A Major Factor Restraining Market Growth
Figure 21 Estimated Total Addressable Market Potential for Neuropathic Pain Management Devices Among Diabetic Patients, 2015
Figure 22 Increasing Number of Patients Suffering From Neuropathic Pain to Offer New Growth Opportunities to Market Players
Figure 23 Presence of Alternative Therapies for Pain Management is A Major Market Challenge
Figure 24 Porter’s Five Forces Analysis (2016): Presence of A Large Number of Manufacturing Firms Increases Competition
Figure 25 Neurostimulation Devices Segment is the Fastest-Growing Segment of the Global Pain Management Devices Market
Figure 26 Neuropathic Pain Segment to Grow at the Highest CAGR in the Forecast Period
Figure 27 Over-The-Counter Segment to Witness Higher Growth During the Forecast Period of 2016 to 2021
Figure 28 Pain Management Devices Market: Growth Forecast, By Region (2016–2021)
Figure 29 North America: Pain Management Devices Market Snapshot
Figure 30 Asia-Pacific: Pain Management Devices Market Snapshot
Figure 31 Leading Market Players Adopted New Product Launches as Their Key Growth Strategy From 2012 to 2016
Figure 32 Global Pain Management Devices Market Share, By Key Player, 2015
Figure 33 New Product Launches and Product Approvals Was the Key Strategy Adopted By Market Players
Figure 34 Geographic Revenue Mix of the Top Market Players (2015)
Figure 35 Medtronic PLC: Company Snapshot
Figure 36 ST. Jude Medical, Inc.: Company Snapshot
Figure 37 Boston Scientific Corporation: Company Snapshot
Figure 38 Hospira, Inc.: Company Snapshot
Figure 39 Halyard Health, Inc.: Company Snapshot
Figure 40 Smiths Medical: Company Snapshot
Figure 41 B. Braun Melsungen AG: Company Snapshot
Figure 42 Becton, Dickinson and Company: Company Snapshot
Figure 43 Nevro Corp.: Company Snapshot

Pain management device are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore the ability of patients to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions.

The global pain management devices market is estimated to grow at a CAGR of 8.5% from 2016 to 2021 to reach USD 4.64 Billion by 2021. The growth in this market is primarily driven by factors such as the presence of a large patient population base and adverse effects associated to the use of pain medications.

Based on type, the pain management devices market is categorized into neurostimulation devices (transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS)), ablation devices (RF ablation and cryoablation), and analgesic infusion pumps (intrathecal and external infusion pumps). The neurostimulation devices segment is expected to account for the largest share of the market in 2016. This can majorly be attributed to the cost-effectiveness of neurostimulation devices, high efficacy of TENS and SCS devices in alleviating chronic pain, and availability of reimbursement for SCS therapy in developed countries.

On the basis of applications, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications (pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain). The neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain.

On the basis of mode of purchase, the market is categorized into over-the-counter and prescription-based pain management device. The prescription-based devices segment is estimated to command a larger share, majorly due to the longer market presence of these devices with established safety and efficacy profiles and their long-term cost effectiveness.

In 2015, North America accounted for the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of chronic diseases, increasing government support, and growing middle-class population and disposable income levels in this region.

Leading players in the pain management devices market are focusing on the strategies of new product launch and geographic expansion. These strategies help market players to strengthen their product portfolios, streamline their manufacturing capabilities, expand their distribution networks, and penetrate into high-growth markets.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) were the top players in the pain management devices market in 2015.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst